Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1884.0000 -15.70 (-0.83%)
NSE Nov 13, 2026 15:31 PM
Volume: 232.7K
 

1884.00
-0.83%
Emkay
Ipca’s 4QFY26 EBITDA was ahead of our expectations (broadly in line with the consensus’). The beat was driven by higher overall sales, a marginally higher gross margin, as well as lower staff costs.
Ipca Laboratories has gained 25.07% in the last 6 Months
More from Ipca Laboratories Ltd.
Recommended